glp-1 prescription reimbursement reporting requirements hr Employer FAQs on the Rise of Drugs for Weight Loss and the Workplace Impact Navigating Changes to GLP-1 Medication

Risk differences were attenuated among metformin monotherapy users (2.0 and 4.1) compared with users of 2 or more diabetes medications (5.7 and 4.0) versus SGLT2is and DPP4is, respectively

That structural difference, rather than any difference in the active ingredient, is what creates the gap that makes treatment reachable for people paying entirely out of pocket

No, maintenance sessions and good skincare habits are needed to maintain the glow

Li H, Zhang Y, Zhang Y et al (2025) Inhibition of oxidative stress and the Neuropilin-2-induced neuroinflammatory pathway by EMO ameliorates epileptic seizures in the preclinical model of epilepsy

Saxenda contains the active ingredient liraglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist

Tirzepatide (Mounjaro, Zepbound) is usually stopped about 1 month before attempting pregnancy